Home/ Supplements/ Omega 3/ Eskimo-3 Stable Fish Oil

Eskimo-3 Stable Fish Oil

product on market Softgel Capsule Integrative Therapeutics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The primary active ingredient is fish oil, which contains omega-3 fatty acids. There is strong evidence that these nutrients support cardiovascular health and cognitive function. Research indicates these ingredients are generally well-tolerated and safe for most individuals.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Eskimo-3 Stable Fish Oil
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
35
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
Cholesterol
5 mg (2% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Vegetable Glycerin Water Soy Lecithin Tocopherol Complex extract of Rosemary Ascorbyl Palmitate Lime flavor
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: Take 3 softgels with meals one to three times daily, or as recommended by your healthcare professional.

Warnings & Precautions

If taking prescription drugs, consult your healthcare professional prior to use.

Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, corn, dairy products, or artificial coloring.

Certified Kosher and Pareve Used only for medical reasons

Additional Information

LZ72297.A01 (BLK229A)

Rabbi Meir Horden The Jewish Community of Stockholm, Sweden

Product of Sweden

Metadata

Product Details

UPC / SKU8 71791 00025 4
DSLD Entry Date2017-09-21
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID76955
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.